FDA approval of Lifyorli plus nab-paclitaxel offers a new option for platinum-resistant epithelial ovarian cancer after 1 to 3 prior systemic regimens.
The oral molecular glue degrader aims to overcome resistance to standard ALK tyrosine kinase inhibitor therapies.
Amneal Pharmaceuticals is recalling Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, Lot AH250162.
HealthDay News — For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 ...
Adstiladrin may now be thawed in a water bath following an FDA label update, facilitating more efficient treatment delivery ...
The diabetes drugs, which usually cost about $525, are listed on TrumpRx starting around $55. The COPD inhaler drops from about $276 to $35, according to the White House. “Those are pretty significant ...
HealthDay News — Removing fluoride from drinking water could lead to more cavities in kids and higher health care costs, a ...
Increased fluid intake; diet with normal to high calcium, low protein, low sodium; thiazides may reduce stone recurrence.
HealthDay News — Cardinal Health is recalling some of its alcohol prep pads after tests found possible bacterial ...
Results from the phase 3 SENTRY trial show that selinexor plus ruxolitinib significantly reduced spleen volume in patients with myelofibrosis.
No increased risk for preterm birth seen in association with periconceptional exposure to GLP-1 receptor agonists for weight ...
Thromboprophylaxis initiation is recommended for active hematological or gynecological cancers during pregnancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results